Sean Whooley is an Assistant Editor at MassDevice. He specializes in medicine and healthcare, particularly focusing on healthcare technology, medical equipment innovations, and corporate finance within the medical sector. Sean's work has been featured in various outlets, including NewsBreak, The Robot Report, and Drug Discovery & Development.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Sean Whooley's articles predominantly focus on healthcare and pharmaceuticals, with a specific emphasis on medical technology, FDA approvals, medical devices, and the pharmaceutical industry. His coverage heavily features press releases and private sector announcements.
To effectively reach out to Sean, consider providing access to exclusive interviews or insights from key figures within the healthcare and pharmaceutical sectors. Additionally, offering in-depth analysis of new technologies or regulatory developments in the medical field could be particularly appealing to him. Given his interest in scientific themes as well, pitches related to cutting-edge research or technological advancements may also capture his attention.
This information evolves through artificial intelligence and human feedback. Improve this profile .
The U.S. Federal Trade Commission (FTC) today said it secured $12 million in a settlement with Edwards (NYSE:EW) and Genesis MedTech.
Dexcom (Nasdaq:DXCM) announced today that Health Canada authorized its G7 15 Day continuous glucose monitor (CGM) system.
Sentante announced today that it unveiled Inflante, its precision-controlled digital indeflator for modernizing balloon inflation.
Newronika announced today that it secured CE mark for its latest adaptive deep brain stimulation (aDBS) system.
By: Sean Whooley
Insulet (Nasdaq:PODD) announced today that it has partnered with Calm, a leading consumer mental health company.
SS Innovations (Nasdaq:SSII) announced today that it appointed Sarah Romano to the position of chief financial officer (CFO).
Zimmer Biomet (NYSE:ZBH) announced today that it appointed Chintan Desai as president of Asia Pacific, effective immediately.
Think Surgical announced today that it entered into a debt facility with Symbiotic Capital worth up to $65 million in growth capital.
By: Sean Whooley
Vermon announced last week that it acquired Modeleus, opened a new TransducerWorks manufacturing facility and launched the Vermon Group.
Kestra Medical Technologies (Nasdaq:KMTS) announced today that it entered into a five-year term loan facility worth $200 million.
